These results suggest that obesity-induced abnormal glucose metabolism could be alleviated in 5-cholestenone-fed db/db mice by reducing the production of inflammatory cytokines through suppression of the NFκB signaling pathway. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.